Publications by authors named "Thomas V Riley"

Recent increases in community-associated infections have highlighted the importance of monitoring toxigenic from animal and environmental sources. We provide the complete circularized genomes of two toxigenic strains isolated from feral horse faeces. Genome N64 (sequence type 964) consists of a single chromosome of 4,078,791 bp, while genome H251 (sequence type 963) comprises one chromosome (4,304,722 bp) and three plasmids (150,942 bp, 11,534 bp, and 9,074 bp).

View Article and Find Full Text PDF

infection (CDI) remains a significant public health threat globally. New interventions to treat CDI rely on an understanding of the evolution and epidemiology of circulating strains. Here we provide longitudinal genomic data on strain diversity, transmission dynamics and antimicrobial resistance (AMR) of ribotypes (RTs) 014/020 (=169), 002 (=77) and 056 (=36), the three most prominent strains causing CDI in Australia.

View Article and Find Full Text PDF

is a leading cause of infectious diarrhea in humans and production animals and can be found in a variety of environmental sources. The prevalence and diversity of multi-locus sequence type clade 5 strains of in Australian production animals suggest Australia might be the ancestral home of this lineage of One Health importance. To better understand the role of the environment in the colonization of humans and animals in Australia, it is important to investigate these endemic sources.

View Article and Find Full Text PDF

There has been a decrease in healthcare-associated infection in Australia, but an increase in the genetic diversity of infecting strains, and an increase in community-associated cases. Here, we studied the genetic relatedness of isolated from patients at a major hospital in Melbourne, Australia. Diverse ribotypes were detected, including those associated with community and environmental sources.

View Article and Find Full Text PDF
Article Synopsis
  • CDI poses a significant risk for gastrointestinal diseases in both humans and animals, necessitating a broader view for its control due to rising community infections and inter-species transmission.
  • A study of 752 fecal samples from horses in Western Australia revealed a 30.9% prevalence of CDI, with significant findings of toxigenic strains linked to human infections.
  • Whole-genome analysis indicated close genetic relationships between equine, human, and environmental strains, suggesting potential transmission pathways and emphasizing the importance of a One Health approach to monitoring and management.
View Article and Find Full Text PDF

Aims: To investigate the prevalence, molecular type, and antimicrobial susceptibility of Clostridioides difficile in the environment in Vietnam, where little is known about C. difficile.

Methods And Results: Samples of pig faeces, soils from pig farms, potatoes, and the hospital environment were cultured for C.

View Article and Find Full Text PDF

Background: Clostridioides (Clostridium) difficile causes antimicrobial-associated diarrhoea, however, presentations may range from asymptomatic carriage to severe diarrhoea, life-threatening toxic megacolon and even death. Reports on C. difficile infection (CDI) in Vietnam remain limited.

View Article and Find Full Text PDF
Article Synopsis
  • New narrow-spectrum antibiotics for Clostridioides difficile infection (CDI) are changing how we measure treatment success from just after therapy to 30 days later.
  • The current way of defining successful treatment, based on the number of unformed bowel movements (UBMs), isn't really working and might make it hard to know if a treatment was successful long-term.
  • The authors suggest better ways to define success in trials, like having fewer UBMs per day and looking at stool types a short time after treatment ends.
View Article and Find Full Text PDF
Article Synopsis
  • * Among the 94 isolates investigated, 71% showed similarities indicating relapse with the original strain, while the rest indicated reinfections with new strains, complicating management strategies for these infections.
  • * The findings suggest potential gaps in current definitions of rCDI based on timing, highlighting the need for updated criteria to account for strain transmission and variations in within-host strain diversity.
View Article and Find Full Text PDF

There is growing evidence that shows () is a pathogen of One Health importance with a complex dissemination pathway involving animals, humans, and the environment. Thus, environmental discharge and agricultural recycling of human and animal waste have been suspected as factors behind the dissemination of Clostridium difficile in the community. Here, the presence of C.

View Article and Find Full Text PDF

This review describes the current understanding of Clostridium (Clostridioides) difficile infection (CDI) in southeast Asia regarding the prevalence of CDI, C. difficile detection methods, antimicrobial susceptibility profiles, and the potential significance of a One Health approach to prevention and control. Our initial focus had been the Indochina region, however, due to limited studies/surveillance of CDI in Indochina, other studies in southeast Asian countries and neighboring Chinese provinces are presented here for comparison.

View Article and Find Full Text PDF

Clostridioides (Clostridium) difficile infection (CDI) places a burden on healthcare facilities worldwide. Most research studies have been concentrated in high-income countries in North America, Europe, Asia and Australia, where C. difficile is the leading cause of diarrhoea associated with antimicrobial use.

View Article and Find Full Text PDF

Background: Clostridioides (Clostridium) difficile commonly causes hospital-acquired infection which can range from mild diarrhoea to life-threatening toxic megacolon and even death. Reports on C. difficile infection (CDI) in Vietnam are limited, so this study was designed to evaluate the prevalence, molecular epidemiology and antimicrobial susceptibility of C.

View Article and Find Full Text PDF

PCR ribotype (RT) 017 ranks among the most successful strains of in the world. In the past three decades, it has caused outbreaks on four continents, more than other ‘epidemic’ strains, but our understanding of the genomic epidemiology underpinning the spread of RT 017 is limited. Here, we performed high-resolution phylogenomic and Bayesian evolutionary analyses on an updated and more representative dataset of 282 non-clonal RT 017 isolates collected worldwide between 1981 and 2019.

View Article and Find Full Text PDF

Colonization of the gastrointestinal (GI) tract with pathogenic bacteria is an important risk factor for the development of certain potentially severe and life-threatening healthcare-associated infections, yet efforts to develop effective decolonization agents have been largely unsuccessful thus far. Herein, we report modification of the 1,2,4-oxadiazole class of antimicrobial compounds with poorly permeable functional groups in order to target bacterial pathogens within the GI tract. We have identified that the quaternary ammonium functionality of analogue results in complete impermeability in Caco-2 cell monolayers while retaining activity against GI pathogens and multidrug-resistant (MDR) .

View Article and Find Full Text PDF

Background And Aims: Clostridium (Clostridiodes) difficile clade 3 ribotype (RT) 023 strains that fail to produce black colonies on bioMérieux ChromID agar have been reported, as well as variant strains of C. difficile that produce only toxin A. We have recently isolated strains of C.

View Article and Find Full Text PDF

Less is understood about the epidemiology of Clostridioides difficile infection (CDI) in children compared to adults, and its impact is complicated by variations in the natural development of infection in paediatric patients. The interplay of rising CDI incidence in hospitalised paediatric patients, emergence of hypervirulent strains and community associated CDI (CA-CDI) in the past decade is a potential threat in both hospital and community settings. Research in Australia regarding paediatric CDI is limited.

View Article and Find Full Text PDF

Clostridium (Clostridioides) difficile infection (CDI) remains an urgent threat to patients in health systems worldwide. Recurrent CDI occurs in up to 30% of cases due to sustained dysbiosis of the gut microbiota which normally protects against CDI. Associated costs of initial and recurrent episodes of CDI impose heavy financial burdens on health systems.

View Article and Find Full Text PDF

Objectives: Increasing incidence rates of Clostridium difficile infection (CDI) and outbreaks of emerging strains have highlighted the need for continuous monitoring and surveillance of CDI in Australia. Active surveillance captures all hospital-identified CDI cases in Western Australia (WA), where all C. difficile isolates recovered are routinely PCR ribotyped.

View Article and Find Full Text PDF

Clostridioides (Clostridium) difficile presents a significant health risk to humans and animals. The complexity of the bacterial-host interaction affecting pathogenesis and disease development creates an ongoing challenge for epidemiological studies, control strategies and prevention planning. The recent emergence of human disease caused by strains of C.

View Article and Find Full Text PDF

Objectives: The aim of this study was to investigate antimicrobial-resistant Bacteroides fragilis in Thailand and possible effects of such strains on human health and disease.

Methods: Phenotypic antimicrobial susceptibility testing was performed on 17 clinical B. fragilis isolates.

View Article and Find Full Text PDF